Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to PRDS Stock Lookup

(PRDS) – FDA

Apr 3, 2023 08:02 AM Pardes Biosciences (PRDS) Announces Top-line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of COVID-19
Feb 14, 2022 07:30 AM Pardes Biosciences (PRDS) Reports Interim Clinical Data from Ongoing PBI-0451 Phase 1 Trial
Feb 3, 2022 07:01 AM

Back to PRDS Stock Lookup